Life Sciences Tools and Services
Company Overview of BioNano Genomics, Inc.
BioNano Genomics, Inc. operates as a genome mapping company. The company develops Irys, a flexible platform capable of providing single-molecule analysis of extremely long DNA. Its platform provides researchers and clinicians an organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. The company’s Irys system includes IrysPrep reagent kits that supplement readily available enzymes with other enzymes, dyes, and buffers needed to label non-amplified DNA for the Irys system; IrysChips for sample handling of precious or minute samples in a convenient 2-flowcell format; Irys Instrum...
9640 Towne Centre Drive
San Diego, CA 92121
Founded in 2003
Key Executives for BioNano Genomics, Inc.
Chief Executive Officer, President and Director
Founder and Chief Scientific Officer
Chief Financial Officer and Vice President of Finance
Vice President of Corporate Development
Compensation as of Fiscal Year 2015.
BioNano Genomics, Inc. Key Developments
BioNano Genomics, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 08:40 AM
Oct 31 15
BioNano Genomics, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 08:40 AM. Venue: Westin Grand Central, New York, New York, United States.
DNAnexus and BioNano Genomics Collaborate to Expand Access to Next-Generation Mapping
Oct 5 15
DNAnexus, Inc. and BioNano Genomics, Inc. jointly announced that the companies have entered into a collaboration that offers access to BioNano's genome analysis algorithms and pipeline on the DNAnexus Platform. IrysSolve is designed to provide researchers with the capability of performing comprehensive analysis of the whole genome, with the computational power and scalability of the DNAnexus Cloud Genomics Platform. DNAnexus provides a secure and compliant cloud environment where researchers can run high-speed, high-throughput, parallel analyses in a rapid and cost-efficient manner. The flexibility of the DNAnexus Platform supports multiple data types including long and short-read sequencing and next-generation mapping formats. Through this collaboration, BioNano offers a pre-configured, full-scale version of the BioNano Genomics computational pipeline, including applications for assembly, hybrid scaffolding, and structural variation calling. This integrated solution provides the ability for enterprises of any size to run IrysSolve from anywhere in the world, and the ability to collaborate securely and share data efficiently in a centralized and controlled environment.
BioNano Genomics, Inc. Presents at UBS Genomics 2.0 Summit, Aug-12-2015 06:30 PM
Aug 10 15
BioNano Genomics, Inc. Presents at UBS Genomics 2.0 Summit, Aug-12-2015 06:30 PM. Venue: The St. Regis Deer Valley, Park City, Utah, United States. Speakers: R. Erik Holmlin, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|